Aviva’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-82,864
Closed -$1.35M 1010
2023
Q1
$1.35M Buy
82,864
+30,020
+57% +$565K 0.01% 818
2022
Q4
$935K Sell
52,844
-24,796
-32% -$493K ﹤0.01% 898
2022
Q3
$1.52M Sell
77,640
-17,201
-18% -$365K 0.01% 784
2022
Q2
$1.89M Buy
94,841
+11,911
+14% +$266K 0.01% 863
2022
Q1
$2.14M Sell
82,930
-7,827
-9% -$203K 0.01% 825
2021
Q4
$2.29M Buy
90,757
+30,214
+50% +$836K 0.01% 843
2021
Q3
$1.63M Buy
+60,543
New +$1.74M 0.01% 844

Other funds holding PETS

Aviva's PETS Position: Q2 2023 in Review

Aviva sold out of PetMed Express (PETS) in Q2 2023, closing a stake of 82,864 shares — an estimated $1.35M sold.

Aviva first reported a position in PETS in Q3 2021 and held it in 7 quarters. The position peaked at $2.29M in Q4 2021. 149 funds tracked by Wall St. Rank hold PETS as of Q2 2023.

  • Aviva reported no remaining PetMed Express position as of Q2 2023 after selling out during the quarter.
  • Aviva sold 82,864 PetMed Express shares in Q2 2023, an estimated $1.35M.
  • Aviva first reported a position in PetMed Express in Q3 2021 and held it in 7 quarters.
  • Aviva's PetMed Express position peaked at $2.29M in Q4 2021.
  • 149 funds tracked by Wall St. Rank held PetMed Express as of Q2 2023.

Based on Aviva's 13F filing for Q2 2023, filed 10 Aug 2023.